Navigation Links
Paid Diabetes Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Age 18+ with Type 2 Diabetes
Date:12/17/2012

efficacy, safety and convenience.

PRIMARY OBJECTIVE

To confirm superiority of insulin degludec/liraglutide versus unchanged glucagon-like peptide-1 (GLP-1) receptor agonist therapy in controlling glycaemia in insulin naïve subjects with type 2 diabetes mellitus (T2DM) inadequately controlled on GLP-1 receptor agonist therapy in combination with metformin.

SECONDARY OBJECTIVE

To compare general efficacy and safety of insulin degludec/liraglutide versus unchanged GLP-1 receptor agonist therapy in insulin naïve subjects with T2DM inadequately controlled with GLP-1 receptor agonist therapy in combination with metformin after 26 weeks of treatment.

TRIAL DESIGN

A 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naïve subjects with T2DM inadequately controlled on a maximum tolerated dose or maximum dose according to local label of GLP-1 receptor agonist and metformin.

Subjects will be randomized in a 2:1 manner into one of the two treatment arms:

  • Once daily insulin degludec/liraglutide added to pre-trial dose of metformin therapy or
  • Unchanged pre-trial GLP-1 receptor agonist in combination with metformin

The randomization will be stratified according to pre-trial type of GLP-1 receptor agonist. The total duration of the trial is approximately 29 weeks consisting of 2 weeks screening period and 26 weeks treatment period and a follow-up visit 1 week after end of treatment. During the 26 week treatment period the subjects will have weekly contacts with the site.

KEY INCLUSION CRITERIA


Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. How a cancer drug leads to diabetes
2. Heart failure patients with diabetes may benefit from higher glucose levels
3. Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study
4. Mouse Study Hints at New Path for Diabetes Treatment
5. Common Plastics Chemical Might Boost Diabetes Risk
6. Weight-Loss Surgery Beat Drugs for Cutting Diabetes in Very Obese
7. Naturopathic care can improve blood sugar, mood in diabetes
8. Cellular pathway linked to diabetes, heart disease
9. Diabetes Groups Issue New Guidelines on Blood Sugar
10. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
11. Xenotransplantation as a therapy for type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... Author Vincent N. Cefalu, Sr., MD. has always believed that ... of them aren’t aware of many products that are detrimental ... realize the dangers of physical inactivity and the many dangerous ... exist. There is also the fact that smokers ... In “ A Doctor’s Prescription for Longevity and Survival ” ...
(Date:5/25/2015)... The National Association of Professional ... inductee into its VIP Professional Woman of the Year ... leadership in dentistry. NAPW is the nation's leading networking ... members and over 200 operating local chapters. , ... of professional women,” said NAPW President Star Jones. “Her ...
(Date:5/25/2015)... 2015 The National Association of ... as a 2015-2016 inductee into its VIP Woman ... prestigious distinction for leadership in biomedical engineering. NAPW is ... boasting more than 700,000 members and over 200 operating ... this exceptional group of professional women," said NAPW President ...
(Date:5/25/2015)... York, New York (PRWEB) May 25, 2015 ... distributor of patented products, launches the Big Little Party ... to customize the perfect table that will suit their ... a whopping revenue of $646 billion this past year. ... a year industry" says Scott J. Cooper, CEO and ...
(Date:5/25/2015)... 24Hr HomeCare is proud to announce that David Allerby, ... Ryan Iwamoto, Co-Founder & CMO, are Finalists for the ... in Greater Los Angeles. The award is presented by ... performance, and a personal commitment to their communities. , ... success of our organization,” said Co-Founder & CEO, David ...
Breaking Medicine News(10 mins):Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 2Health News:New Book Reveals ‘A Doctor’s Prescription for Longevity and Survival’ 3Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lisa Ferrara, Ph.D., CEO of OrthoKinetic Technologies, Into its VIP Professional Woman of the Year Circle 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 2Health News:Party Time - Top Officials Get Excited About World Patent Marketing's New Party Invention For Entertainment 3Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2
... On Wednesday, September 14, Allan Coukell, a pharmacist and ... will testify before the Senate Health Education Labor and ... ensure the safety of the U.S. drug supply. ... now originate outside the U.S. Increasingly, Americans rely ...
... , FRIDAY, Sept. 9 (HealthDay News) -- One-third of ... metabolic disorder, a new study finds. This disorder ... naturally from many foods -- that has a foul, fishy ... disease that impairs the ability of an enzyme to metabolize ...
... human papillomavirus (HPV) vaccine Cervarix may be just as effective ... measures against cervical cancer, according to a new study published ... Cancer Institute . Across the globe, cervical cancer is ... 16 and 18 are a large contributor to the development ...
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. 8 ... or the death of a child in infancy have an ... study suggests. Researchers from the United Kingdom looked at ... stillborn child between 1971 and 2006 or whose child died ...
... each year with stage III or,locally advanced ... a viable,treatment option. Optimizing nonsurgical treatment strategies ... In an article published online,September 8, 2011 ... Institute, RTOG,researchers report that treating patients with ...
... HealthDay Reporter , THURSDAY, Sept. 8 (HealthDay News) -- ... rise, reaching 22.6 million, or 8.9 percent of the population, ... has largely been driven by more marijuana use, according to ... fact, in 2010 some 17.4 million Americans were using marijuana, ...
Cached Medicine News:Health News:Fewer than 3 doses of cervical cancer vaccine effective 2Health News:Losing Child in First Year Might Raise Early Death Risk for Parent 2Health News:Losing Child in First Year Might Raise Early Death Risk for Parent 3Health News:Concurrent chemo and radiation therepy improves long-term survival for inoperable stage III lung cancer 2Health News:More U.S. Adults Using Illegal Drugs: Report 2Health News:More U.S. Adults Using Illegal Drugs: Report 3
(Date:5/22/2015)... Fla. , May 22, 2015 ... Heart Institute recently traveled to Boston, ... procedure at the 2015 Heart Rhythm Society conference. ... together to focus on the ideas, people and ... Convergent is a hybrid, minimally invasive cardiac ...
(Date:5/22/2015)... -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development ... announced that J.J. Finkelstein , chief executive officer ... at two upcoming investor conferences. Mr. ... Annual Microcap Conference on Thursday May 28, 2015 in ... am EDT.  A webcast will be available at the ...
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... of the results of the Company,s 72-patient, placebo-controlled ... drops) for the treatment of dry eye patients ... ) model.  The exploratory study was completed in ... disseminated by the Company in a press release, ...
Breaking Medicine Technology:St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 2St. Joseph's Hospital Heart Institute Physician Presents at Heart Rhythm Society 3RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: